发明名称 BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE
摘要 PROBLEM TO BE SOLVED: To provide an oral composition for reducing serum cholesterol, serum lipids, body fat, or atherogenic index or for prophylaxis or treatment of atherosclerosis, cardiovascular or cerebrovascular diseases, comprising a highly bsh active bacteria or an isolate or supernatant thereof.SOLUTION: With the oral composition, the highly bsh active bacteria degrades more than 50 μmol glycodeoxycholic acid (GDCA)/gram/hour and more than 2 μmol taurodeoxycholic acid (TDCA)/gram/hour when measured over 1 hour and 5 hours, respectively, or degrades more than 65 μmol GDCA/g/hour and more than 7 μmol TDCA/g/hour when measured over 30 minutes.
申请公布号 JP2015127338(A) 申请公布日期 2015.07.09
申请号 JP20150063056 申请日期 2015.03.25
申请人 UAS LABORATORIES LTD 发明人 PRAKASH SATYA;MITCHELL LAWRENCE JONES;CHRISTOPHER MARTONI
分类号 A61K35/74;A23L1/30;A61K9/08;A61K9/20;A61K9/48;A61K9/50;A61K9/51;A61K9/70;A61K31/11;A61K31/133;A61K31/155;A61K31/192;A61K31/195;A61K31/198;A61K31/201;A61K31/202;A61K31/216;A61K31/22;A61K31/351;A61K31/366;A61K31/397;A61K31/40;A61K31/4015;A61K31/403;A61K31/404;A61K31/4418;A61K31/4439;A61K31/445;A61K31/451;A61K31/47;A61K31/4985;A61K31/505;A61K31/513;A61K31/55;A61K31/56;A61K31/575;A61K31/64;A61K31/7016;A61K31/7034;A61K31/714;A61K31/785;A61K35/744;A61K35/745;A61K35/747;A61K36/68;A61K38/00;A61K38/22;A61K45/00;A61K47/10;A61K47/12;A61K47/22;A61K47/24;A61K47/26;A61K47/28;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61K47/46;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P13/12;A61P25/00;A61P31/22;A61P35/00;A61P37/06;A61P43/00 主分类号 A61K35/74
代理机构 代理人
主权项
地址